Biomarker Discovery & Validation
News on biomarker discovery and validation for research and diagnostic use in genetics, genomics, and molecular diagnostics.
CityUHK, Cellomics to Develop Circulating Tumor Cell Screening Platform
Within two years, the team hopes to commercialize an assay that combines cell sorting, staining, and imaging, as well as protein and gene profiling.
Precision Medicine Startup Ataraxis AI Nabs $20.4M in Series Financing
Ataraxis AI will use the new funding to bring to market its first offering, Ataraxis Breast, an AI-native prognostic/predictive platform for breast cancer.
Sapient Partnering With Alamar Bio to Offer Proteomics Services on NULISA Platform
Sapient will be an Alamar certified service provider for Alamar's NULISAseq Inflammation panel and its NULISAseq CNS Disease panel.
Grifols Secures $21M MJFF Grant to Search for Early Parkinson's Biomarkers
Grifols subsidiary Alkahest will lead a pilot study to track proteomic changes in patient plasma samples over a 10-year period.
Liquid Biopsy Developer Oxford Cancer Analytics Raises $11M
The company, which is based in England and has operations in Canada, is developing a liquid biopsy test for lung cancer detection.